文献速递糖尿病

改善血清25-羟维生素D状态对糖尿病患者血糖控制的影响:一项荟萃分析

The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该系统评价与荟萃分析检索至2017年1月的文献,纳入24项对照试验共1528例2型糖尿病患者,评估补充维生素D对血糖和胰岛素抵抗的影响。结果显示补充维生素D后HbA1c、空腹血糖和HOMA-IR均显著降低,血清25-羟维生素D水平显著升高。作者认为每日最低剂量100 µg(4000 IU)的维生素D补充可能显著改善2型糖尿病患者的血糖控制和胰岛素敏感性。

要点

  • 补充维生素D后HbA1c平均降低0.30%(95%CI -0.45至-0.15,P<0.001)。
  • 空腹血糖平均降低4.9 mg/dL(0.27 mmol/L),HOMA-IR平均降低0.66。
  • 血清25-羟维生素D总体平均升高17±2.4 ng/mL(42±6 nmol/L)。

核心结论

  • 作者认为每日最低剂量100 µg(4000 IU)的维生素D补充可能显著降低2型糖尿病患者的空腹血糖、HbA1c和HOMA-IR,有助于控制血糖反应并改善胰岛素敏感性。

研究设计与样本

  • 系统评价与荟萃分析,检索PUBMED/Medline、Cumulative Index to Nursing and Allied Health及Cochrane Library(截至2017年1月),系统评价注册号CRD42017059555。
  • 从文献检索共844条记录中纳入24项对照试验,共1528例确诊2型糖尿病患者。
  • 纳入评估维生素D补充对糖化血红蛋白(HbA1c)、空腹血糖(FPG)和稳态模型胰岛素抵抗评估(HOMA-IR)影响的前瞻性临床试验。
  • 采用随机效应模型合成定量数据,并用留一法进行敏感性分析。

主要发现

  • 补充维生素D后HbA1c平均差异为-0.30%(95%CI -0.45至-0.15,P<0.001)。
  • 空腹血糖平均差异为-4.9 mg/dL(-0.27 mmol/L),95%CI -8.1至-1.6(-0.45至-0.09 mmol/L),P=0.003。
  • HOMA-IR平均差异为-0.66(95%CI -1.06至-0.26,P=0.001)。
  • 血清25-羟维生素D水平总体平均升高17±2.4 ng/mL(42±6 nmol/L)。

关键数值与推荐

  • 作者结论提出维生素D补充的最低剂量为100 µg/d(4000 IU/d)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type 2 diabetes is a global health concern, with an increased prevalence and high cost of treatment. OBJECTIVE: The aim of this systematic review and meta-analysis was to determine the effect of vitamin D supplementation and improved vitamin D status on glycemia and insulin resistance in type 2 diabetic patients. DATA SOURCE: We searched PUBMED/Medline, Cumulative Index to Nursing and Allied Health, and Cochrane Library (until January 2017). STUDY SELECTION: Prospective clinical trials were selected evaluating the impact of vitamin D supplementation on glycosylated hemoglobin (HbA1c), serum fasting plasma glucose (FPG), and homeostatic model assessment of insulin resistance (HOMA-IR) in diabetic patients. DATA EXTRACTION AND SYNTHESIS: We used a random-effects model to synthesize quantitative data, followed by a leave-one-out method for sensitivity analysis. The systematic review registration was CRD42017059555. From a total of 844 entries identified via literature search, 24 controlled trials (1528 individuals diagnosed with type 2 diabetes) were included. The meta-analysis indicated a significant reduction in HbA1c [mean difference: -0.30%; 95% confidence interval (CI): -0.45 to -0.15, P < 0.001], FPG [mean difference: -4.9 mg/dL (-0.27 mmol/L); 95% CI: -8.1 to -1.6 (-0.45 to -0.09 mmol/L), P = 0.003], and HOMA-IR (mean difference: -0.66; 95% CI: -1.06 to -0.26, P = 0.001) following vitamin D supplementation and significant increase in serum 25-hydroxyvitamin D levels [overall increase of 17 ± 2.4 ng/mL (42 ± 6 nmol/L)]. CONCLUSIONS: Vitamin D supplementation, a minimum dose of 100 µg/d (4000 IU/d), may significantly reduce serum FPG, HbA1c, and HOMA-IR index, and helps to control glycemic response and improve insulin sensitivity in type 2 diabetic patients.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mirhosseini N, Vatanparast H, Mazidi M, et al. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab. 2017. PMID: 28957454. doi:10.1210/jc.2017-01024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。